Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M8,526Revenue $M260Net Margin (%)20.2Z-Score31.3
Enterprise Value $M7,848EPS $0.9Operating Margin %27.6F-Score6
P/E(ttm))102Cash Flow Per Share $0.2Pre-tax Margin (%)27.6Higher ROA y-yN
Price/Book13.010-y EBITDA Growth Rate %0Quick Ratio5.7Cash flow > EarningsY
Price/Sales20.15-y EBITDA Growth Rate %0Current Ratio6.0Lower Leverage y-yY
Price/Cash Flow306y-y EBITDA Growth Rate %51.0ROA % (ttm)12.1Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)15.0Less Shares Outstanding y-yY
Payout Ratio %0Shares Outstanding M75.0ROI % (ttm)2.8Gross Margin Increase y-yN

Gurus Latest Trades with PCYC

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
PCYCJoel Greenblatt 2014-06-30 Add0.08%$85.85 - $107.42
($93.89)
$ 115.5723%Add 724.62%79,089
PCYCMariko Gordon 2014-06-30 Sold Out -0.04%$85.85 - $107.42
($93.89)
$ 115.5723%Sold Out0
PCYCMariko Gordon 2014-03-31 Add0.02%$100.49 - $151.61
($129.71)
$ 115.57-11%Add 112.41%9,295
PCYCJoel Greenblatt 2014-03-31 Buy 0.01%$100.49 - $151.61
($129.71)
$ 115.57-11%New holding, 9591 sh.9,591
PCYCMariko Gordon 2013-12-31 Add0.01%$99.28 - $139.59
($121.32)
$ 115.57-5%Add 130.07%4,376
PCYCMariko Gordon 2013-09-30 Buy 0.01%$84.5 - $132.49
($110.93)
$ 115.574%New holding, 1902 sh.1,902
PCYCJoel Greenblatt 2013-03-31 Sold Out -0.14%$57.78 - $94.2
($77.47)
$ 115.5749%Sold Out0
PCYCJoel Greenblatt 2012-12-31 Buy 0.14%$47.87 - $69.78
($58.72)
$ 115.5797%New holding, 41832 sh.41,832
PCYCGeorge Soros 2012-06-30 Sold Out -0.04%$25.72 - $53.44
($32.62)
$ 115.57254%Sold Out0
PCYCGeorge Soros 2012-03-31 Buy 0.04%$14.99 - $28.68
($20.91)
$ 115.57453%New holding, 100000 sh.100,000
PCYCPRIMECAP Management 2011-06-30 Add0.01%$5.66 - $10.63
($7.17)
$ 115.571512%Add 21.34%4,011,958
PCYCPRIMECAP Management 2010-06-30 Add0.01%$5.53 - $8.18
($6.98)
$ 115.571556%Add 43.36%3,306,481
PCYCPRIMECAP Management 2009-09-30 Add$1.2299 - $2.32
($1.49)
$ 115.577656%Add 51.48%2,300,678
PCYCPRIMECAP Management 2009-06-30 Reduce$1.02 - $1.39
($1.24)
$ 115.579220%Reduce -27.71%1,518,800
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

PCYC is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
PCYC Joel Greenblatt 2014-06-3079,0890.110.09+724.62%
PCYC - CALLMariko Gordon 2014-06-304,0000.010.02
PCYC PRIMECAP Management 2014-06-302,313,0393.080.23-2.84%
PCYC Mariko Gordon 2014-06-30000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


PCYC: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Zanganeh MakyCOO 2014-09-04Sell12,000$121.75-2.28view
Love Richard BGeneral Counsel 2014-08-27Sell1,500$124-4.05view
Fardis MariaChief of Oncology Ops & Allian 2014-08-13Sell4,000$121.01-1.68view
Tan HeowChief Quality&Tech Operations 2014-08-13Sell10,000$123.58-3.72view
McGreivy JesseChief Medical Officer 2014-08-07Sell34,062$120.92-1.6view
Fardis MariaChief of Oncology Ops & Allian 2014-03-05Sell3,000$140.5-15.32view
McGreivy JesseChief Medical Officer 2014-03-05Sell6,563$139.66-14.81view
Sjovall Boultbee Paula SEVP, Sales and Marketing 2014-03-05Sell20,000$138.22-13.92view
Hemmi GregorySr. VP Chemical Operations 2014-03-05Sell15,000$140-15.01view
HALVORSON ERIC HDirector 2014-03-04Sell3,472$138.33-13.99view

Press Releases about PCYC :

    Quarterly/Annual Reports about PCYC:

    News about PCYC:

    Articles On GuruFocus.com
    Weekly Insider Sells Highlight: BX, PCYC, MAS, ITMN Mar 03 2014 
    comment on PCYC Mar 06 2013 
    Weekly CEO Buys Highlight: PCYC, HLX, FSC, CREG, BTX Jun 25 2011 
    Pharmacyclics Inc. Reports Operating Results (10-Q) Feb 08 2011 
    Pharmacyclics Inc. Reports Operating Results (10-Q) Nov 09 2010 
    Weekly CEO Buys Highlight: Pharmacyclics Inc, Saul Centers Inc, Charming Shoppes Inc, ProLogis, Exce Jun 27 2010 
    Pharmacyclics Inc. Reports Operating Results (10-Q) May 07 2010 
    cooldecency99 note on PCYC May 01 2010 
    cooldecency99 note on PCYC May 01 2010 
    Pharmacyclics Inc. Reports Operating Results (10-Q) Nov 03 2009 


    More From Other Websites
    PHARMACYCLICS INC Files SEC form 8-K, Termination of a Material Definitive Agreement, Other Events,... Sep 30 2014
    Pharmacyclics and Servier Agree to Conclude Pan-HDAC Inhibitor Collaboration Sep 25 2014
    Gilead's Zydelig Approved In EU; Imbruvica In Wings Sep 19 2014
    Pharmacyclics Price Target Cut On Higher Spending Sep 08 2014
    SunTrust Robinson Humphrey Starts Coverage on 5 Top Biotech Stocks Sep 08 2014
    Infinity Pharma Joins AbbVie On Blood Cancer Drug Sep 03 2014
    PHARMACYCLICS INC Files SEC form 8-K, Change in Directors or Principal Officers Aug 29 2014
    Target Expected To Be Right On Target With Earnings Aug 20 2014
    Pharmacyclics Appoints Chief Commercial Officer Aug 18 2014
    PHARMACYCLICS INC Financials Aug 15 2014
    PHARMACYCLICS INC Files SEC form 8-K/A, Financial Statements and Exhibits Aug 14 2014
    Pharmacyclics Has Edge Over Blood Cancer Competitors Aug 13 2014
    PHARMACYCLICS INC Files SEC form 8-K, Other Events Aug 08 2014
    PHARMACYCLICS INC Files SEC form 10-Q, Quarterly Report Aug 08 2014
    PHARMACYCLICS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Aug 04 2014
    Pharmacyclics Incurs Q2 Loss, Revenues Up on Imbruvica Sales Aug 01 2014
    Pharmacyclics Q2 Earnings Get Mixed Reception Aug 01 2014
    The Best Blood Cancer Drug Launch Ever? Aug 01 2014
    Pharmacyclics upgraded by WallachBeth Aug 01 2014
    PHARMACYCLICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Jul 31 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK